Fluconazole improves survival in septic shock: A randomized double-blind prospective study

Critical Care Medicine

Volumn 31, Issue 7, 2003, Pages 1938-1946

  Jacobs, Sydney ^a   Evans, David A Price ^a   Tariq, Mohammed ^a   Al Omar, Nasser Fawzan ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Fluconazole; Intra abdominal sepsis; Mortality; Multiple organ failure; Nosocomial pneumonia; Septic shock

Indexed keywords

FLUCONAZOLE; PLACEBO;

ABDOMINAL INFECTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HOSPITAL INFECTION; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SURVIVAL RATE;

EID: 0042868282     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000074724.71242.88     Document Type: Article

References (55)

1. Carrico CJ, Meakins JL, Marshall JC: Multiple organ failure syndrome. Arch Surg 1986; 121:196-208
2. Knaus WA, Draper EA, Wagner DP, et al: Prognosis in acute organ system failure. Ann Surg 1986; 202:685-692
3. Zimmerman JE, Knaus WA: A comparison of risk and outcomes for patients with organ system failure. Crit Care Med 1996; 24:1982-1990
4. Rangel-Frausto M, Pitter D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study. JAMA 1995; 273:934-941
5. Thomas L: The lives of a cell. New York, Viking Press, 1974, 78:9
6. Carey PD, Jenkins JK, Byrne K, et al: Neutrophil short-lived oxidant production: Enhancement following onset of sepsis-induced lung injury. Circ Shock 1992; 36:256-264
7. Chang RWS, Jacobs S, Lee B: Predicting outcome among intensive care unit patients using computerized trend analysis of daily APACHE II scores corrected for organ system failure. Intensive Care Med 1988; 14:558-566
8. Marshall JC, Cook D, Christou NV, et al: Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 1995; 23:1638-1652
9. Rowan-Kelly B, Ferrante A, Thong YH: Modification of polymorphonuclear leukocyte function by imidazoles. Int J Immunopharmacol 1984; 6:389-393
10. Marmer DJ, Fields BT, France GL, et al: Ketoconazole, amphotericin B and amphotericin B methyl ester: Comparative in vitro toxicological effects on neutrophil function. Antimicrob Agents Chemother 1981; 20:660-665
11. Alford RH, Cartwritght BB: Comparison of ketoconazole and amphotericin B in interference with thymidine uptake by and blastogenesis of lymphocytes stimulated with Histoplasma capsulatum antigens. Antimicrob Agents Chemother 1983; 24:575-578
12. Johnson EM, Warnock DW, Richardson MD, et al: In vitro effect of itraconazole, ketoconazole, and amphotericin B on phagocytic and candidacidal function of human neutrophils. J Antimicrob Chemother 1986; 18:83-91
13. Vuddhakul V, Mai GT, McCormack JG, et al: Suppression of neutrophil and lymphoproliferative responses in vitro by itraconazole but not fluconazole. Int J Immunopharmacol 1990; 12:639-645
14. Vuddhakul V, McCormack JG, Seow WK, et al: Effects of the newer antifungal agents (bifonazole, ICI 195739, and amorolfin) on in vitro phagocytic, lymphocytic and natural-killer cell responses. Int J Immunopharmacol 1989; 11:817-827
15. Slotman GJ, Burchard KW, D'Arezzo A, et al: Ketoconazole prevents acute respiratory failure in critically ill surgical patients. J Trauma 1988; 28:648-654
16. Yu M, Tomasa G: A double blind, prospective, randomized trial of the adult respiratory distress syndrome. Crit Care Med 1993; 21:1635-1641
17. Sinuff T, Cook DJ, Peterson JC, et al: Development, implementation, and evaluation of a ketoconazole practice guideline for ARDS prophylaxis. J Crit Care 1999; 14:1-6
18. Lecuk S, Huval WV, Valeri CR: Inhibition of ischaemia-induced thromboxane synthesis in man. J Trauma 1984; 24:393-396
19. Slotman GJ, Yellin SA, Handy JR, et al: Thromboxane A mediates haemodynamic and respiratory dysfunction in graded bacteraemia. Surgery 1986; 100:214-220
20. Steinhilber D, Jaschonek K, Knospe J, et al: Effects of novel antifungal azole derivatives on 5-lipo-oxygenase and cyclo-oxygenase pathways. Arzneimittelforschung 1990; 40:1260-1263
21. Zervos EE, Fink GW, Norman JG, et al: Fluconazole increases bactericidal activity of neutrophils. J Trauma 1996; 41:10-14
22. Zervos EE, Fink GW, Norman JG, et al: Fluconazole increases bactericidal activity of neutrophils through non-cytokine mediated pathway. J Trauma 1996; 41:465-470
23. Salartash K, Gallucci J, Quinn J, et al: The cardio-pulmonary, eicosanoid and microanatomical effects of fluconazole during graded bacteraemia. Shock 1996; 6:206-212
24. British National Formulary, British Medical Association and Royal Pharmaceutical Society of Great Britain. London, The Pharmaceutical Press, Royal Pharmaceutical Society of Great Britain
25. Albert SG, DeLeon MJ, Silverberg AB: Possible association between high-dose fluconazole and adrenal insufficiency in critically ill patients. Crit Care Med 2001; 29:668-670
26. Summary of recommendations. Intensive Care Med 2001; 27:S128-S134
27. American College of Chest Physicians/Society of Critical Care Consensus Conference: Definitions for sepsis and multiple organ failure. Crit Care Med 1992; 20:864-874
28. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
29. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Crit Care Med 1994; 149:818-824
30. Pugin J, Aukenthaler R, Mill N, et al: Diagnosis of ventilator-associated pneumonia by bacteriological analysis of bronchoscopic and non-bronchoscopic 'blind' bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143:1121-1129
31. Jorda R, Parras F, Ibanez J, et al: Diagnosis of nosocomial pneumonia in mechanically ventilated patients by the blind protected telescoping catheter. Intensive Care Med 1993; 19:377-382
32. Papazian L, Thomas P, Garbe L, et al: Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 1995; 152:1982-1991
33. Jacobs S, Zuleika M, Mphansa T: The multiple organ dysfunction score as a descriptor of patient outcome in septic shock compared with two other scoring systems. Crit Care Med 1999; 27:741-744
34. Jacobs S, Ali I, Zuleika M, et al: Calculated total radical antioxidant potential compared in outcome groups of septic shock. Clin Intensive Care 1999; 10:7-12
35. Horn R, Wong B, Kiehn TE, et al: Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985; 7:646-655
36. Eggiman P, Francioli P, Bille J, et al: Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999; 27:1066-1072
37. Eggimann P, Pittet D: Invasive candida infections in critically ill patients. Schweiz Med Wochenschr 2000; 130:1525-1537
38. Ward PA, Till GO, Warren JS: Pathophysiology of leukocyte-mediated tissue injury. J Crit Care 1991; 6:112-116
39. Engler RL, Dahlgren MD, Morris D, et al: Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1983; 251:H314-323
40. Grisham MB, Everse J, Janssen HF: Endotoxemia and neutrophils activation in vivo. Am J Physiol 1988; 254:H1017-1022
41. Fukatsu K, Saito H, Han I, et al: Concomitant increase in neutrophil adherence to inflammatory peritoneum and remote organs during peritonitis. J Surg Res 1999; 81:156-163
42. Burch RM, Noronha-Blob L, Bator JM, et al: Mice treated with a leumedin or antibody to Mac-1 to inhibit leukocyte sequestration survive endotoxin challenge. J Immunol 1993; 150:3397-3403
43. Bator JM, Weitzberg M, Burch RM: N-(9H-(2,7-dimethylfluorenyl-9-methoxy)carbonyl)-L-leucine, NPC 15669, prevents neutrophil adherence to endothelium and inhibits CD11b/CD18 upregulation. Immunopharmacology 1992; 23:139-149
44. Pou S, Gunther MR, Pou WS, et al: The effect of NPC 15669, an inhibitor of neutrophil recruitment and neutrophil mediated inflammation, on neutrophil function in vitro. Biochem Pharmacol 1993; 45:2123-2127
45. Noonha-Blob L, Lowe VC, Otterbein L, et al: NPC 15669 reduces mortality associated with sepsis in rats. J Pharmacol Exp Ther 1993; 267:664-669
46. Eppinger MJ, Jones ML, Deeb M, et al: Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J Surg Res 1995; 58:713-718
47. Lupetti A, Danesi R, Campa M, et al: Molecular basis of resistance to azole antifungals. Trends Mol Med 2002; 8:76-81
48. Levy RH: Cytochrome-P450 isoenzymes and anti-epileptic drug interactions. Epilepsia 1995; 36:S8-S13
49. Black DJ, Kunze KL, Wienkers LC, et al: Warfarin-fluconazole. II. A metabolically based drug interaction: In vivo studies. Drug Metab Dispos 1996; 24:422-428
50. Zhang WJ, Ramamoorthy Y, Kilicarslan T, et al: Inhibition of cytochromes P450 by anti-fungal imidazole derivatives. Drug Metab Dispos 2002; 30:314-318
51. Matute-Bello G, Frevert CW, Kajikawa O, et al: Septic shock and acute lung injury in rabbits with peritonitis. Am J Crit Care Med 2001; 163:234-243
52. Fox-Dewhurst R, Alberts M, Kajikawa O, et al: Pulmonary and systemic inflammatory responses in rabbits with gram-negative pneumonia. Am J Respir Crit Care Med 1997; 155:2030-2040
53. Heeken RI, Gandawidjaja L, Hau T: Peritonitis: Pathophysiology and local defense mechanisms. Hepatogastroenterology 1997; 44:927-936
54. Matthay MA, Folkesson HG, Verkman AS: Salt and water transport across alveolar and distal airway epithelia in adult lung. Am J Physiol 1996; 270:L487-L503
55. Brun-Buisson C, Doyon F, Carlet J: Bacteraemia and severe sepsis in adults: A multicentre prospective survey in ICUs and wards of 24 hospitals. French Bacteraemic-Sepsis Study Group. Am J Respir Crit Care Med 1996; 154:617-624